Going Up to 7.5mg Mounjaro: What to Expect at This Dose

What SURMOUNT-1 tells us about where 7.5mg sits on the dose-response curve

The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults with obesity across tirzepatide doses of 5mg, 10mg and 15mg versus placebo over 72 weeks. The results showed a clear dose-response relationship: more drug, more weight loss, on average. The 5mg group saw around 16% body-weight reduction; the 15mg group, around 21%. That gradient matters when you're thinking about 7.5mg.

The licensed schedule doesn't jump straight to a therapeutic dose. It starts at 2.5mg (a level chosen to let your system adjust) and moves upward in four-week steps. By the time you reach 7.5mg, your body has had at least eight weeks to adapt. That process is intentional: it's how the drug's developers and regulators designed it to be used, and the NICE appraisal of tirzepatide (TA1026) endorsed that approach when recommending the medicine for adults with a BMI of 35 or above plus at least one weight-related condition.

Put simply, 7.5mg is not where the dose-response flattens out. Most people have more room to go if they need it and tolerate the medicine well. Whether to move there is a clinical judgement, not a default.

Why side effects can reappear briefly when you go up to 7.5mg

If you sailed through 5mg, you might notice a return of nausea or looser stools in the first week or two at 7.5mg. That's not unusual. Each dose increase is a new adjustment period, and the GI effects that many people experience at the start of treatment can resurface briefly at each step upward. The common profile (nausea, indigestion, changes in bowel habit, fatigue) tends to settle within days to around two weeks for most people.

One practical detail: some people find the timing of their weekly injection affects how noticeable those effects are. Taking it before a quieter day, or keeping the pen in the same place in the fridge door so it becomes part of a fixed routine, can help reduce the chance of forgetting and then injecting on an unexpectedly busy morning. Small habits, but they add up.

If side effects at 7.5mg are significant and persistent, your prescriber may discuss staying at the lower dose longer rather than pushing up on schedule. The move from 5mg to 7.5mg is a step many people take smoothly, but not everyone moves at the same pace, and that's fine. It's also worth reading about how side effects typically behaved at the earlier dose increase, since the pattern is similar.

What happens after 7.5mg, and whether you'll need to go higher

Two questions tend to come up around this point: do I have to keep increasing, and how do I know if 7.5mg is working?

The short answer is no, you don't have to increase. The licensed maximum is 15mg, but the right dose for any individual is the lowest one that produces meaningful weight loss and is tolerated well. Some people maintain good progress at 7.5mg and stay there for an extended period with their prescriber's agreement. Others find the pace of loss slows and, after clinical review, move to 10mg.

NICE guidance (TA1026) notes that if a person has not lost at least 5% of their body weight after six months at the highest tolerated dose, continuing treatment should be reviewed. That benchmark applies to the full course, not just one dose level. At 7.5mg, most people are mid-journey rather than at a ceiling.

For context on how costs scale across the dose schedule, the Eli Lilly UK price increase from September 2025 is worth understanding, particularly at higher doses, where per-pen list prices rose substantially. Knowing the pricing landscape at each step helps you plan ahead. You can explore all dose options and what they involve on the Mounjaro overview page, or if you're thinking about the wider treatment picture, the weight-loss treatment overview sets out how Mounjaro fits alongside other licensed options.

The prescriber's role at each dose step

Going up to any new dose, including 7.5mg, requires a clinical sign-off, not just a repeat of the same order. At a service like nume, every repeat involves a fresh review by a GPhC-registered Independent Prescriber. That means someone is actively looking at whether 7.5mg is appropriate for you, not just processing a renewal automatically.

What that review considers includes how you've tolerated 5mg, whether you've lost weight in line with reasonable expectations, and whether any new symptoms need attention before escalating. Evidence of your current weight is part of that picture, and if you're ever unsure how your pen's unit markings translate to a milligram dose, it's worth checking how many mg is 100 units of tirzepatide, since understanding that conversion can help you feel more confident reading your device. The clinical infrastructure around these dose changes matters, especially given the MHRA's strong warnings about counterfeit pens and unregulated online sellers operating without proper prescribing oversight.

If you have questions about where you are on the schedule or whether 7.5mg is the next right step for you, speaking directly with a prescriber is the most useful thing you can do. You can start a free consultation with our prescribers, and the same-day clinical review means you won't be waiting long for a considered answer.